Nestle Chief Executive Officer Mark Schneider said GLP-1 obesity drugs like Wegovy will probably increase demand for a range of food products that can help avoid nutrient deficiencies...

Written by Charles-Henry Monchau | Feb 23, 2024 11:05:45 AM

View full post